A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome

Condition:   Cushing Syndrome Interventions:   Drug: ATR-101;   Drug: Placebos Sponsor:   Millendo Therapeutics, Inc. Not yet recruiting - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials